BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26463629)

  • 21. HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation.
    Chen B; Zhao J; Zhang S; Zhang Y; Huang Z
    Oncol Rep; 2016 Dec; 36(6):3664-3672. PubMed ID: 27748944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
    Ekpe-Adewuyi E; Lopez-Campistrous A; Tang X; Brindley DN; McMullen TP
    Oncotarget; 2016 Dec; 7(50):83684-83700. PubMed ID: 27845909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD; Zuo Y; Xu Z; Zhang M
    World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.
    Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C
    Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.
    Wu CY; Zheng C; Xia EJ; Quan RD; Hu J; Zhang XH; Hao RT
    Med Sci Monit; 2020 Jan; 26():e919820. PubMed ID: 31902939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of Latent Transforming Growth Factor-β (TGF-β)-Binding Protein 2 (LTBP2) Inhibits Invasion and Tumorigenesis in Thyroid Carcinoma Cells.
    Wan F; Peng L; Zhu C; Zhang X; Chen F; Liu T
    Oncol Res; 2017 Apr; 25(4):503-510. PubMed ID: 27712597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Pathway.
    Min X; Liu K; Zhu H; Zhang J
    Med Sci Monit; 2018 Jul; 24():4592-4601. PubMed ID: 29969438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma.
    Chong ST; Tan KM; Kok CYL; Guan SP; Lai SH; Lim C; Hu J; Sturgis C; Eng C; Lam PYP; Ngeow J
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5573-5584. PubMed ID: 31290966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition.
    Shu C; Wang S; Hu J; Xu M; Deng H; Maimaiti Y; Huang T
    J Endocrinol Invest; 2023 Mar; 46(3):545-557. PubMed ID: 36306106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of the PIK3CA gene in anaplastic thyroid cancer.
    García-Rostán G; Costa AM; Pereira-Castro I; Salvatore G; Hernandez R; Hermsem MJ; Herrero A; Fusco A; Cameselle-Teijeiro J; Santoro M
    Cancer Res; 2005 Nov; 65(22):10199-207. PubMed ID: 16288007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
    Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y
    Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu W; Xu Z; Zhang M; Zuo Y
    Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
    Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
    Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA circ_0067934 Overexpression Correlates with Poor Prognosis and Promotes Thyroid Carcinoma Progression.
    Wang H; Yan X; Zhang H; Zhan X
    Med Sci Monit; 2019 Feb; 25():1342-1349. PubMed ID: 30779728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway.
    Gao W; Han J
    Biomed Pharmacother; 2018 Feb; 98():265-270. PubMed ID: 29272787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.